Stem Cell Manufacturing Global Market Report 2024

Description

“Stem Cell Manufacturing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The stem cell manufacturing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Consumables; Instruments; Stem Cell Lines
2) By Application: Research Applications; Clinical Application; Cell and Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic Institutes, Research Laboratories And Contract Research Organizations; Hospitals And Surgical Centers; Cell And Tissue Banks; Other End Users
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck Millipore; Stemcell Technologies; Fujifilm Holdings Corporation; Takara Bio Group
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Stem cell manufacturing involves the technologies required to transition stem cell tissue culture from laboratory settings to clinical applications, ensuring controlled, reproducible, automated, validated, and safe production for therapeutic purposes.

The primary products within stem cell manufacturing comprise consumables, instruments, and stem cell lines. Consumables are utilized in growing new cells within culture media, contributing to applications in drug development, tissue culture, gene therapy, and toxicity testing. These consumables serve diverse purposes across research, clinical applications, and cell and tissue banking. They are used by a range of end-users including pharmaceutical and biotechnology companies, academic institutes, research laboratories, contract research organizations, hospitals and surgical centers, as well as cell and tissue banks.

The stem cell manufacturing market research report is one of a series of new reports from The Business Research Company that provides stem cell manufacturing market statistics, including stem cell manufacturing industry global market size, regional shares, competitors with a stem cell manufacturing market share, detailed stem cell manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell manufacturing industry. This stem cell manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell manufacturing market size has grown rapidly in recent years. It will grow from $15.78 billion in 2023 to $17.39 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth observed during the historical period can be attributed to several factors, including advancements in biotechnology that expanded capabilities, increased research and development initiatives focused on stem cell technologies, the progression of clinical trials and their therapeutic applications, the establishment of regulatory frameworks governing stem cell use, and substantial investments in infrastructure supporting stem cell research and applications.

The stem cell manufacturing market size is expected to see rapid growth in the next few years. It will grow to $26.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period is expected to be driven by increased funding and investments in stem cell research, the expanding scope of therapeutic applications, the emergence and advancement of cell-based therapies, a rise in the number of clinical trials and subsequent approvals, and the development of customized and patient-specific therapies. Key trends projected in the forecast period encompass a heightened focus on 3D bioprinting techniques within stem cell research, the continued expansion and utilization of induced pluripotent stem cells (iPSCs), integration of automation and robotics in stem cell manufacturing processes, efforts towards standardization and scalability in stem cell technologies, as well as advancements in bioreactor technology enhancing the cultivation and utilization of stem cells for various applications.

The rise in the geriatric population is set to drive the growth of the stem cell manufacturing market. The term 'geriatric population' pertains to individuals aged 65 and older who often experience various diseases due to compromised immunity and aging. The prevalence of chronic diseases increases with age, and stem cell manufacturing holds promise in combating these conditions. According to the United Nations Department of Economic and Social Affairs' September 2020 report, the global population aged 65 and above is projected to increase from 9.3% in 2020 to approximately 16.0% in 2050. Furthermore, a World Health Organization factsheet from October 2021 projects that there will be 1.4 billion individuals over the age of 60 worldwide by 2030, up from 1 billion in 2020. Consequently, the escalating geriatric population is a driving force behind the expansion of the stem cell manufacturing market.

The burgeoning biotechnology industry is expected to fuel the growth of the stem cell manufacturing market. The biotechnology sector, a rapidly expanding field, encompasses a wide range of products and services utilizing living organisms or their components to develop new technologies and solutions. Stem cell manufacturing, as a rapidly growing domain within biotechnology, has the potential to revolutionize the industry by creating novel therapies and treatments for various diseases. Notably, in March 2022, Airswift reported a 39.6% increase in capital invested in biotech companies, rising from $48 billion in 2020 to $67 billion in 2021. This substantial growth in the biotechnology industry is a key driver behind the expanding stem cell manufacturing market.

Technological advancement stands out as a crucial trend in the stem cell manufacturing market, with various stakeholders focusing on leveraging advanced technologies for sustainability. A noteworthy example is Cellino, a US-based biotech company specializing in stem cell manufacturing, which, in September 2021, integrated AI, machine learning, hardware, software, and lasers to enhance yields and reduce production expenses related to human cell production. This innovative approach eliminates human annotation and unpredictability by utilizing machine learning and AI, illustrating the importance of technological advancements in driving efficiency and progress within the stem cell manufacturing market.

Major companies within the stem cell manufacturing market are actively pursuing the development of innovative products, with a focus on GM-grade protein to attain a competitive advantage. GM-grade protein is a designation indicating that protein powders and related products meet specific standards for quality and safety. A noteworthy example is ACROBiosystems Inc., a US-based provider of recombinant proteins and critical reagents, which, in November 2023, introduced GM-grade DLL4 protein. This recombinant, soluble form of Delta-such as Ligand 4 (DLL4), a crucial signaling molecule in stem cell development and differentiation, signifies a significant milestone for advancing stem cell-based therapies. The availability of GMP-grade DLL4 ensures a high-quality, consistent, and scalable source of this essential protein, known for promoting the self-renewal and expansion of hematopoietic stem cells (HSCs). Its utilization in stem cell cultures enhances the growth and differentiation of HSCs, contributing to advancements in stem cell research and therapies.

In June 2021, Catalent, a New Jersey-based developer and producer of delivery methods for pharmaceuticals, biologics, and consumer health products, executed the acquisition of RheinCell Therapeutics GmbH for an undisclosed amount. This strategic move aimed to expand the creation of upcoming cell treatments and significantly enhance Catalent's capacity for large-scale production. RheinCell Therapeutics GmbH, a Germany-based manufacturer, specializes in GMP-grade human-induced pluripotent stem cells (iPSCs). The acquisition strengthens Catalent's position in the stem cell manufacturing market, emphasizing the importance of securing capabilities in producing high-quality stem cell materials for therapeutic applications.

Major companies operating in the stem cell manufacturing market report are Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Chemical Pharma Co. Ltd., AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group, Vericel Corporation .

North America was the largest region in the stem cell manufacturing market in 2023. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the stem cell manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stem cell manufacturing market consists of sales of adult stem cells (ASCs), human embryonic stem cells (HESCs), induced pluripotent stem cells (iPSCs), and very small embryonic-such as cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11365

1. Executive Summary

2. Stem Cell Manufacturing Market Characteristics

3. Stem Cell Manufacturing Market Trends And Strategies

4. Stem Cell Manufacturing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Stem Cell Manufacturing Market Size and Growth

5.1. Global Stem Cell Manufacturing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Stem Cell Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Stem Cell Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Stem Cell Manufacturing Market Segmentation

6.1. Global Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Consumables
Instruments
Stem Cell Lines
6.2. Global Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Research Applications
Clinical Application
Cell and Tissue Banking Applications
6.3. Global Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic Institutes, Research Laboratories And Contract Research Organizations
Hospitals And Surgical Centers
Cell And Tissue Banks
Other End Users

7. Stem Cell Manufacturing Market Regional And Country Analysis

7.1. Global Stem Cell Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Stem Cell Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Stem Cell Manufacturing Market

8.1. Asia-Pacific Stem Cell Manufacturing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Stem Cell Manufacturing Market

9.1. China Stem Cell Manufacturing Market Overview
9.2. China Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Stem Cell Manufacturing Market

10.1. India Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Stem Cell Manufacturing Market

11.1. Japan Stem Cell Manufacturing Market Overview
11.2. Japan Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Stem Cell Manufacturing Market

12.1. Australia Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Stem Cell Manufacturing Market

13.1. Indonesia Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Stem Cell Manufacturing Market

14.1. South Korea Stem Cell Manufacturing Market Overview
14.2. South Korea Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Stem Cell Manufacturing Market

15.1. Western Europe Stem Cell Manufacturing Market Overview
15.2. Western Europe Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Stem Cell Manufacturing Market

16.1. UK Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Stem Cell Manufacturing Market

17.1. Germany Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Stem Cell Manufacturing Market

18.1. France Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Stem Cell Manufacturing Market

19.1. Italy Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Stem Cell Manufacturing Market

20.1. Spain Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Stem Cell Manufacturing Market

21.1. Eastern Europe Stem Cell Manufacturing Market Overview
21.2. Eastern Europe Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Stem Cell Manufacturing Market

22.1. Russia Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Stem Cell Manufacturing Market

23.1. North America Stem Cell Manufacturing Market Overview
23.2. North America Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Stem Cell Manufacturing Market

24.1. USA Stem Cell Manufacturing Market Overview
24.2. USA Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Stem Cell Manufacturing Market

25.1. Canada Stem Cell Manufacturing Market Overview
25.2. Canada Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Stem Cell Manufacturing Market

26.1. South America Stem Cell Manufacturing Market Overview
26.2. South America Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Stem Cell Manufacturing Market

27.1. Brazil Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Stem Cell Manufacturing Market

28.1. Middle East Stem Cell Manufacturing Market Overview
28.2. Middle East Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Stem Cell Manufacturing Market

29.1. Africa Stem Cell Manufacturing Market Overview
29.2. Africa Stem Cell Manufacturing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Stem Cell Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Stem Cell Manufacturing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Stem Cell Manufacturing Market Competitive Landscape And Company Profiles

30.1. Stem Cell Manufacturing Market Competitive Landscape
30.2. Stem Cell Manufacturing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck Millipore
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Stemcell Technologies
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Fujifilm Holdings Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Takara Bio Group
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Stem Cell Manufacturing Market Competitive Benchmarking

32. Global Stem Cell Manufacturing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Manufacturing Market

34. Stem Cell Manufacturing Market Future Outlook and Potential Analysis

34.1 Stem Cell Manufacturing Market In 2028 - Countries Offering Most New Opportunities
34.2 Stem Cell Manufacturing Market In 2028 - Segments Offering Most New Opportunities
34.3 Stem Cell Manufacturing Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer